Trademark Overview
On Thursday, February 23, 2023, a trademark application was filed for DAXXIFY with the United States Patent and Trademark Office. The USPTO has given the DAXXIFY trademark a serial number of 97809052. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 27, 2024. This trademark is owned by Revance Therapeutics, Inc.. The DAXXIFY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; Dermatological pharmaceutical products and pharmaceutical preparations injected into or under the skin, into or under mucous membranes for filling in wrinkles, skin depressions for remodeling, increasing volume in the face or any other part of the body, for moisturizing the skin or mucous membranes, for increasing lip volume
